Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer

Yamamoto,Taketsugu; Oshima,Takashi; Yoshihara,Kazue; Nishi,Teppei; Arai,Hiromasa; Inui,Kenji; Kaneko,Takeshi; Nozawa,Akinori; Adachi,Hiroyuki; Rino,Yasushi; Masuda,Munetaka; Imada,Toshio

doi:10.3892/etm.2012.493

Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer

Authors:
- Taketsugu Yamamoto
- Takashi Oshima
- Kazue Yoshihara
- Teppei Nishi
- Hiromasa Arai
- Kenji Inui
- Takeshi Kaneko
- Akinori Nozawa
- Hiroyuki Adachi
- Yasushi Rino
- Munetaka Masuda
- Toshio Imada
View Affiliations

Affiliations: Department of Surgery, Yokohama City University, Yokohama-city, Kanagawa 236-0004, Japan, Gastroenterological Center, Yokohama City University Medical Center, Yokohama-city, Kanagawa 232-0024, Japan, Respiratory Center, Yokohama City University Medical Center, Yokohama-city, Kanagawa 232-0024, Japan, Department of Pathology, Yokohama City University Medical Center, Yokohama-city, Kanagawa 232-0024, Japan
Published online on: February 22, 2012 https://doi.org/10.3892/etm.2012.493
Pages: 797-802

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Insulin-like growth factor-1 receptor (IGF-1R) and matrix metalloproteinase-7 (MMP-7) have been reported to be related to tumor invasion and metastasis in various malignancies. The aim of this study was to evaluate the expression levels of IGF-1R and MMP-7 in resected non-small cell lung cancer (NSCLC) and to examine the relationship of such levels to clinical characteristics and survival. Expression was measured immunohistochemically. The percentage of stained cells was multiplied by the staining intensity. The sample was classified as high when the score was equal or higher than the median value or was otherwise considered to be low. High IGF-1R expression was associated with nodal metastasis and recurrence (P=0.034 and 0.006, respectively). High IGF-1R expression was associated with significantly poorer overall survival than low IGF-1R expression (P=0.011). MMP-7 expression did not significantly correlate with any clinicopathological factor. There was a trend toward slightly, but not significantly poorer survival in patients with MMP-7-high tumors than in those with MMP-7-low tumors (P=0.220). There was no significant correlation between IGF-1R expression and MMP-7 expression (P=0.184). Upon multivariate analysis, IGF-1R expression was independently related to the outcomes of patients with NSCLC. Overexpression of IGF-1R may be a useful predictor of lymph node metastasis, recurrence and post-surgical outcomes in patients with NSCLC.

View Figures

View References

1.	Dufourny B, Alblas J, van Teeffelen HA, et al: Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem. 272:31163–31171. 1997. View Article : Google Scholar
2.	Khandwala HM, McCutcheon IE, Flyvbjerg A and Friend KE: The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev. 21:215–244. 2000. View Article : Google Scholar : PubMed/NCBI
3.	Baserga R, Hongo A, Rubini M, Prisco M and Valentinis B: The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta. 1332:F105–F126. 1997.PubMed/NCBI
4.	Blakesley VA, Stannard BS, Kalebic T, Helman LJ and LeRoith D: Role of the IGF-I receptor in mutagenesis and tumor promotion. J Endocrinol. 152:339–344. 1997. View Article : Google Scholar : PubMed/NCBI
5.	LeRoith D and Roberts CT Jr: The insulin-like growth factor system and cancer. Cancer Lett. 195:127–137. 2003. View Article : Google Scholar : PubMed/NCBI
6.	Turner BC, Haffty BG, Narayanan L, et al: Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res. 57:3079–3083. 1997.
7.	Long L, Rubin R and Brodt P: Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Exp Cell Res. 238:116–121. 1998. View Article : Google Scholar : PubMed/NCBI
8.	Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 92:827–839. 2003. View Article : Google Scholar : PubMed/NCBI
9.	Mott JD and Werb Z: Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 16:558–564. 2004. View Article : Google Scholar : PubMed/NCBI
10.	Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M and Kanetake H: Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res. 12:6998–7003. 2006. View Article : Google Scholar
11.	Kitoh T, Yanai H, Saitoh Y, et al: Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer. J Gastroenterol. 39:434–440. 2004. View Article : Google Scholar : PubMed/NCBI
12.	Liu D, Nakano J, Ishikawa S, et al: Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer. Lung Cancer. 58:384–391. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Leinonen T, Pirinen R, Bohm J, Johansson R, Ropponen K and Kosma VM: Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis. Lung Cancer. 51:313–321. 2006. View Article : Google Scholar : PubMed/NCBI
14.	Sasaki H, Yukiue H, Moiriyama S, et al: Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J Surg Res. 101:242–247. 2001. View Article : Google Scholar : PubMed/NCBI
15.	Miyamoto S, Yano K, Sugimoto S, et al: Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res. 64:665–671. 2004. View Article : Google Scholar
16.	Adachi Y, Li R, Yamamoto H, et al: Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin. Carcinogenesis. 30:1305–1313. 2009. View Article : Google Scholar : PubMed/NCBI
17.	Dziadziuszko R, Merrick DT, Witta SE, et al: Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. J Clin Oncol. 28:2174–2180. 2010. View Article : Google Scholar : PubMed/NCBI
18.	Cappuzzo F, Tallini G, Finocchiaro G, et al: Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients. Ann Oncol. 21:562–567. 2010. View Article : Google Scholar : PubMed/NCBI
19.	Ludovini V, Bellezza G, Pistola L, et al: High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. Ann Oncol. 20:842–849. 2009. View Article : Google Scholar : PubMed/NCBI
20.	Merrick DT, Dziadziuszko R and Szostakiewicz B: High insulin-like growth factor 1 receptor (IGF1R) expression is associated with poor survival in surgically resected non-small cell lung cancer (NSCLC) patients (pts). J Clin Oncol. 25(Suppl): 75502007.